Clinical trial to compare safety and tolerability between intravenous infusion and bolus intravenous injection of ApTOLL in healthy volunteers by Macarena Hernández-Jiménez, Samuel Martín-Vílchez, Gina Mejía-Abril, Manuel Roman, Sergio Luquero-Bueno, David Piñeiro, Marc Ribó, Francisco Abad-Santos, Dolores Ochoa

Get full text

Impact of Genetic Variants on Pregabalin Pharmacokinetics and Safety by Sofía Calleja, Andrea Rodríguez-López, Dolores Ochoa, Sergio Luquero, Marcos Navares-Gómez, Manuel Román, Gina Mejia-Abril, Samuel Martín-Vilchez, Francisco Abad-Santos, Pablo Zubiaur

Get full text

Polymorphisms Associated with Age at Onset in Patients with Moderate-to-Severe Plaque Psoriasis by Rocío Prieto-Pérez, Guillermo Solano-López, Teresa Cabaleiro, Manuel Román, Dolores Ochoa, María Talegón, Ofelia Baniandrés, José Luis López-Estebaranz, Pablo de la Cueva, Esteban Daudén, Francisco Abad-Santos

Get full text

VACINA DE PREFUSÃO DE PROTEÍNA F DO VÍRUS SINCICIAL RESPIRATÓRIO ADJUVANTADA (RSVPREF3OA) É IMUNOGÊNICA E BEM TOLERADA EM ADULTOS 50-59 ANOS, INCLUINDO ADULTOS COM RISCO AUMENTADO... by Lessandra Michelin, (representando Murdo Ferguson), Tino F. Schwarz, Sebastián A. Núñez, Juan Rodríguez-García, Marek Mital, Carlos Zala, Bernhard Schmitt, Nicole Toursarkissian, Dolores Ochoa Mazarro, Josef Großkopf, Christine Voors-Pette, Hemalini Mehta, Hiwot Amare Hailemariam, Magali de Heusch, Silvia Damaso, Marie-Pierre David, Dominique Descamps, Judith Hill, Corinne Vandermeulen, Veronica Hulstrøm, (representando o grupo de estudo RSV AO=ADJ-018 study group)

Get full text